Clinical trials | Why global networks are crucial to speed up late stage clinical development
Moderator:
- Ron de Winter – Programme Manager European Projects, UMC Utrecht
This content has been restricted to logged in users only. Please login to view this content.
Speakers:
- Seamus O’Brien – R&D Director, GARDP
This content has been restricted to logged in users only. Please login to view this content.
- Tim Jinks – Head of Antibiotic Resistance Infections Program, Wellcome Trust
This content has been restricted to logged in users only. Please login to view this content.
- Florence Séjourné – CEO, DaVolterra & President, BEAM Alliance
This content has been restricted to logged in users only. Please login to view this content.
- Kamini Walia – Head of AMR, ICMR, Government of India
This content has been restricted to logged in users only. Please login to view this content.
Play Video
This might also be of interest for you:
- More information about European Clinical Research Alliance on Infectious Diseases
- By Wellcome Trust: The growing crisis in antibiotic R&D: opportunities for G20 member action to support sustainable innovation & further information on WT’s activities to fight against AMR
- Enabling AMR-related Clinical Trials in India: Network Exploratory Workshop
- Latest news by GARDP can be found here
- Webinar recording by GARDP: The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study
- Wellcome and GARDP in the AMR Stakeholder Guide